Streetbeat News

Products Services

RUM

Rumble has introduced a new feature that allows livestream contributions to U.S. federal political campaigns, enabling tips as campaign contributions. This service is open to channels of any political affiliation and will initially be available to desktop users. Rumble will require users to provide personal information and certify their eligibility to comply with federal disclosure laws.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:04 pm

ABBV

Enigma Biomedical Group USA (EBG-USA) has entered into an exclusive license and option agreement with AbbVie to develop and potentially commercialize AbbVie's F18 PET imaging biomarkers for detecting 4R tau protein in neurodegenerative diseases. The biomarkers could advance understanding and treatment of diseases like PSP and CBD. EBG-USA will collaborate with partners to validate the biomarkers, with an option for an exclusive license if evaluations are positive.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:04 pm

TSLA

Tesla Inc. (NASDAQ:TSLA) is allowing destination-charging property owners to host self-serve demo drives at their properties. Owners can have up to 4 demo vehicles provided by Tesla, which will also manage the scheduling and maintenance of these vehicles. This initiative aims to help property owners get more out of their investment in Tesla's destination charging infrastructure and to increase awareness about EV charging.

Portfolio Pulse from Anan Ashraf

January 18, 2024 | 12:50 pm

EFX

Equifax has renewed its partnership with the National Consumer Telecom and Utilities Exchange, Inc. (NCTUE), continuing its role in providing data solutions for the telecommunications, pay TV, internet, home security, and utility industries.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 12:47 pm

IDEX

Ideanomics' subsidiary WAVE Charging has received a purchase order from an undisclosed retail and logistics company. The size and financial details of the order have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 12:32 pm

DFS

PLUG

QQQ

SPY

TSM

U.S. stock futures indicate a higher opening, with Nasdaq futures surging due to a positive forecast from Taiwan Semiconductor Manufacturing Company Limited (TSMC). The tech sector is expected to benefit from TSMC's optimistic outlook as the tech earnings season begins. Economic data on jobless claims, housing starts, and regional manufacturing activity will be in focus. Analyst Lisa Shalett from Morgan Stanley warns that establishing a new bull market will require more effort than currently anticipated, expecting mid-single-digit returns for U.S. stocks and bonds. Discover Financial Services (DFS) and Plug Power (PLUG) saw premarket declines following their respective earnings release and equity offering announcement. Other companies, including AMD, FAST, FHN, KEY, MTB, NTRS, JBHT, and PPG, are scheduled to report earnings.

Portfolio Pulse from Shanthi Rexaline

January 18, 2024 | 12:31 pm

TCRX

TScan Therapeutics has announced that an abstract has been accepted for oral presentation at the Best Abstracts Session of the 2024 Tandem Meetings of ASTCT and CIBMTR. This could indicate positive developments in their research and potential for increased visibility among the scientific and investment communities.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 12:27 pm

AES

The AES Corporation has completed 3.5 GW of renewable energy projects in 2023, which is nearly double the capacity that the company constructed in 2022. This significant increase in renewable capacity highlights AES's growth in the clean energy sector.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 12:25 pm

VSAT

Viasat has successfully demonstrated a UK Satellite-based Augmentation System, showcasing the potential for highly accurate GPS data to enhance safety and efficiency.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 12:23 pm

MBOT

Microbot Medical has hired a US-based Clinical Research Associate after positive results from its pivotal GLP pre-clinical study. This move is in preparation for its anticipated Investigational Device Exemption (IDE) submission to begin first in human clinical trials.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 12:22 pm